Skip to main content
Caplight Logo









Viroteq

Viroteq

Private
AbcoudeFrontier & Industrial Techhttps://viroteq.ai

Last Round

Seed

Oct 14, 2020

Company Overview

Viroteq operates in Frontier & Industrial Tech and is based in Abcoude. Its latest recorded funding round was a Seed round in October 2020.

Viroteq is a robotics software company that develops AI-driven solutions for intelligent palletizing and logistics automation.

Sector

Frontier & Industrial Tech

Verticals

Computer Vision, Smart Manufacturing, Edge Computing, Quality Management

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Viroteq Comparables

Compare Viroteq with similar companies based on industry and business-model similarity.

Viroteq comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Covision Quality
86%
Overview
83%
SwitchOn
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Viroteq Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 14, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Evert van Galen

Co-Founder and CEO

Founding Team

For institutional investors. Book with your work email.

Viroteq Investors

Notable investors and investment history

Viroteq investors
InvestorRounds
StartLifeSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 14, 2020

    Seed round raised with Horizon Flevoland and StartLife.

Book a demo to see all signals

For institutional investors. Book with your work email.

Viroteq Filings

Explore SEC and related filing metadata, where available.

Viroteq filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Viroteq's valuation, stock price, and market status.

Is Viroteq a public or private company?

Viroteq is a private company.

What is the current stock price of Viroteq?

Viroteq is a private company, so its shares have no public market price. Caplight tracks Viroteq's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Viroteq worth (valuation)?

Valuation information for Viroteq is not publicly available.

Can I buy Viroteq stock?

Viroteq shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Viroteq's last funding round?

Viroteq's most recent funding round was Seed on October 14, 2020.

Who are the main investors in Viroteq?

Key investors in Viroteq include StartLife.

Will Viroteq IPO soon?

No public IPO plans have been announced for Viroteq.

How can I track Viroteq secondary market activity?

Caplight tracks bids, offers, and trades in Viroteq's shares on secondary markets.

Firmographic Details

HeadquartersAbcoude
Employee Range7
Year Founded2018
Last FundingOct 14, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?